- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
All Names： Jyseleca，filgotinib
Indications：active rheumatoid arthritis
Manufacturer：Gilead Sciences,USA
Customs Clearance Procedure：If the customs requires the package for customs clearance, please pay the customs clearance fee according to the content of EMS SMS and customs regulations.
INDICATIONS AND USAGE
Jyseleca is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (DMARDs). Jyseleca may be used as monotherapy or in combination with methotrexate (MTX).
DOSAGE
The recommended dose of filgotinib for adult patients with rheumatoid arthritis is 200 mg once daily.
ADVERSE REACTIONS
The most frequently reported adverse reactions are nausea (3.5%), upper respiratory tract infection (URTI, 3.3%), urinary tract infection (UTI, 1.7%) and dizziness (1.2%).
For full information, please refer to:https://www.medicines.org.uk/emc/product/11809/smpc
Jyselecainformation
No information yet!!!
